Welcome to our dedicated page for Afya news (Ticker: AFYA), a resource for investors and traders seeking the latest updates and insights on Afya stock.
Afya Limited (AFYA) delivers essential medical education and digital health solutions across Brazil through its integrated network and technology platforms. This news hub provides investors and healthcare professionals with centralized access to corporate developments, strategic initiatives, and operational updates.
Track official press releases covering financial results, academic partnerships, technology implementations, and regulatory milestones. Our curated collection includes updates on Afya's three core segments: Undergraduate medical programs, Continuing Education certifications, and Digital Services supporting clinical decision-making.
Key updates feature expansion of educational partnerships, digital tool enhancements for healthcare providers, and growth metrics across Afya's learning platforms. Users benefit from chronological organization of material events and strategic announcements without editorial commentary.
Bookmark this page for streamlined monitoring of Afya's progress in merging traditional medical training with innovative digital solutions. Verify publication dates and consult original filings for complete context on all developments.
Afya Limited (Nasdaq: AFYA) announced on October 13, 2020, the acquisition of 100% of iClinic's share capital for R$182.7 million. The purchase included 61.5% in cash and 38.5% in stock, enhancing Afya's offerings to physicians in Brazil. iClinic is a leading SaaS technology company providing electronic medical records, a clinical management system, telemedicine services, and a physician marketplace. This acquisition aims to establish Afya as a comprehensive platform for medical professionals, strengthening their ability to manage clinics and improve patient care.
Afya Limited (Nasdaq: AFYA) has received authorization from Brazil's Secretary of Regulation and Supervision of Higher Education to operate an undergraduate medicine course in Santa Inês, Maranhão, as part of the Mais Médicos II program. This marks the first medical school associated with the Mais Médicos initiative for Afya and will contribute an additional 50 seats to its operational capacity. Afya is recognized as a leading medical education group in Brazil, focusing on establishing a physician-centric educational ecosystem.
Afya Limited (Nasdaq: AFYA) reported robust financial results for Q2 and H1 2020, driven by a 53.6% YoY increase in Q2 net revenue to R$274.2 million and a 69.2% YoY rise in H1 revenue to R$546.5 million. Adjusted EBITDA surged 76.6% YoY in Q2 to R$118.2 million with a margin of 43.1%. The company achieved an adjusted net income of R$82.6 million in Q2, up 163.1% YoY. Afya’s strong cash position stands at R$1.1 billion, and a series of acquisitions, including PEBMED, are set to enhance its digital health services segment.
Afya Limited (Nasdaq: AFYA) announced the acquisition of FESAR for R$260 million, fully paid in cash. FESAR is a Brazilian post-secondary institution authorized to offer undergraduate medical courses, with medical education comprising 70% of its 2019 revenues. Projected net revenue for FESAR in 2024 is R$88.6 million, with medical courses expected to represent 94% of this total. The deal will add 120 medical school seats to Afya, increasing its total to 2,143. The Q2 2020 earnings call is scheduled for August 28, 2020, to discuss this acquisition further.
Afya Limited (Nasdaq: AFYA) announced its acquisition of Faculdade Ciências Médicas da Paraíba (FCMPB) through its subsidiary, Afya Participações S.A. The purchase price is R$380 million, with 50% paid at closing and the remainder in installments through 2024. FCMPB, which contributes 99% of its revenue from medical courses, is projected to generate R$107 million in revenue by 2024. This acquisition adds 157 medical school seats to Afya, increasing their total to 2,023. The deal is subject to customary conditions, including antitrust approval.
Afya Limited (Nasdaq: AFYA) will report its Q2 2020 financial results on August 27, 2020, after market close. A conference call will be held the following day at 11:00 AM EDT, providing investors with insights into the company's financial performance.
Afya is a prominent medical education group in Brazil, focusing on a comprehensive ecosystem for medical students and professionals.
Afya Limited (Nasdaq: AFYA) announced its acquisition of 100% of PEBMED for R$132.9 million, plus net debt of R$7.1 million. This move enables Afya to enhance its digital platform, particularly in medical decision support tools for professionals. Key products include WhiteBook, with 165,000 monthly active users, and Nursebook, with 20,000 users. The acquisition is expected to expand Afya's market reach and strengthen its offerings. A conference call for investors is scheduled for June 21, 2020.
Afya Limited (Nasdaq: AFYA) reported significant growth in Q1 2020, with Pro forma Net Revenue rising by 27.2% YoY to R$272.3 million. Adjusted EBITDA surged 36.0%, reaching R$140.6 million, while Adjusted Net Income soared 131.7% to R$124.0 million. The company maintained 100% occupancy in medical school seats and increased monthly active users on its platform to 16,008. Afya affirmed its guidance for the first half of 2020, anticipating net revenues between R$475 million and R$510 million, indicating confident growth despite the COVID-19 pandemic.
Afya Limited (Nasdaq: AFYA) updated shareholders on the impact of COVID-19 on its operations. The company successfully transitioned many educational activities online, maintaining positive feedback from students and staff. Practical classes for 5th and 6th-year students have resumed, although some earlier year activities may be postponed, affecting revenue recognition. Despite the pandemic, the company reports no increase in payment delinquency and is providing support for families in need. Afya remains committed to delivering quality education and believes in its strong financial position and strategic approach.
FAQ
What is the current stock price of Afya (AFYA)?
What is the market cap of Afya (AFYA)?
